HIV-seropositive patient with Sweet's syndrome and nodular scleritis, showing dramatic response after adding dapsone to systemic corticosteroid therapy.
Inamadar
Arun C
AC
Department of Dermatology, Venereology and Leprosy, BLDEA's SBMP Medical College, Hospital and Research Center, Bijapur, Karnataka, India. aruninamadar@rediffmail.com
Anitha
B
B
D000284:Administration, Oral; D000328:Adult; D003622:Dapsone / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000175:diagnosis; D006679:HIV Seropositivity; D006801:Humans; D007262:Infusions, Intravenous; D011239:Prednisolone / Q000008:administration & dosage*; D015423:Scleritis / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D016463:Sweet Syndrome / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy* / Q000276:immunology; D016896:Treatment Outcome
D003622:Dapsone; D011239:Prednisolone